Literature DB >> 19737917

Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis.

Takehiko Matsushita1, Yuk Yu Chan, Aya Kawanami, Gener Balmes, Gary E Landreth, Shunichi Murakami.   

Abstract

Osteoblasts and chondrocytes arise from common osteo-chondroprogenitor cells. We show here that inactivation of ERK1 and ERK2 in osteo-chondroprogenitor cells causes a block in osteoblast differentiation and leads to ectopic chondrogenic differentiation in the bone-forming region in the perichondrium. Furthermore, increased mitogen-activated protein kinase signaling in mesenchymal cells enhances osteoblast differentiation and inhibits chondrocyte differentiation. These observations indicate that extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in the lineage specification of mesenchymal cells. The inactivation of ERK1 and ERK2 resulted in reduced beta-catenin expression, suggesting a role for canonical Wnt signaling in ERK1 and ERK2 regulation of skeletal lineage specification. Furthermore, inactivation of ERK1 and ERK2 significantly reduced RANKL expression, accounting for a delay in osteoclast formation. Thus, our results indicate that ERK1 and ERK2 not only play essential roles in the lineage specification of osteo-chondroprogenitor cells but also support osteoclast formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737917      PMCID: PMC2772724          DOI: 10.1128/MCB.01549-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols.

Authors:  Luis Filgueira
Journal:  J Histochem Cytochem       Date:  2004-03       Impact factor: 2.479

Review 2.  Understanding the molecular basis of Apert syndrome.

Authors:  Omar A Ibrahimi; Ernest S Chiu; Joseph G McCarthy; Moosa Mohammadi
Journal:  Plast Reconstr Surg       Date:  2005-01       Impact factor: 4.730

3.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

Authors:  Theo P Hill; Daniela Später; Makoto M Taketo; Walter Birchmeier; Christine Hartmann
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

4.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.

Authors:  Timothy F Day; Xizhi Guo; Lisa Garrett-Beal; Yingzi Yang
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

5.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 6.  Cellular and molecular interactions regulating skeletogenesis.

Authors:  Céline Colnot
Journal:  J Cell Biochem       Date:  2005-07-01       Impact factor: 4.429

Review 7.  Protein-protein interactions in the regulation of the extracellular signal-regulated kinase.

Authors:  Dana Chuderland; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

8.  Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.

Authors:  Nathalie Leclerc; Tommy Noh; Arvinder Khokhar; Elisheva Smith; Baruch Frenkel
Journal:  Arthritis Rheum       Date:  2005-03

9.  Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.

Authors:  Shunichi Murakami; Gener Balmes; Sandra McKinney; Zhaoping Zhang; David Givol; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

Review 10.  Functions of RANKL/RANK/OPG in bone modeling and remodeling.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013

View more
  94 in total

1.  Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal.

Authors:  Arjun Sebastian; Takehiko Matsushita; Aya Kawanami; Susan Mackem; Gary E Landreth; Shunichi Murakami
Journal:  J Orthop Res       Date:  2010-10-04       Impact factor: 3.494

2.  Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.

Authors:  Chunxi Ge; Qian Yang; Guisheng Zhao; Hong Yu; Keith L Kirkwood; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

3.  An Improved Immunostaining and Imaging Methodology to Determine Cell and Protein Distributions within the Bone Environment.

Authors:  Hemanth Akkiraju; Jeremy Bonor; Anja Nohe
Journal:  J Histochem Cytochem       Date:  2015-12-30       Impact factor: 2.479

4.  Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

5.  Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass.

Authors:  Reem Smoum; Arik Bar; Bo Tan; Garry Milman; Malka Attar-Namdar; Orr Ofek; Jordyn M Stuart; Alon Bajayo; Joseph Tam; Vardit Kram; David O'Dell; Michael J Walker; Heather B Bradshaw; Itai Bab; Raphael Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

6.  Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.

Authors:  Qing He; Xuehui Yang; Yan Gong; Dmitry Kovalenko; Ernesto Canalis; Clifford J Rosen; Robert E Friesel
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

7.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

8.  Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.

Authors:  Mylène Tajan; Julie Pernin-Grandjean; Nicolas Beton; Isabelle Gennero; Florence Capilla; Benjamin G Neel; Toshiyuki Araki; Philippe Valet; Maithé Tauber; Jean-Pierre Salles; Armelle Yart; Thomas Edouard
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

9.  c-Raf promotes angiogenesis during normal growth plate maturation.

Authors:  Eva S Liu; Adalbert Raimann; Byongsoo Timothy Chae; Janaina S Martins; Manuela Baccarini; Marie B Demay
Journal:  Development       Date:  2015-12-10       Impact factor: 6.868

10.  Histone deacetylase 3 suppresses Erk phosphorylation and matrix metalloproteinase (Mmp)-13 activity in chondrocytes.

Authors:  Lomeli R Carpio; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  Connect Tissue Res       Date:  2016-09-23       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.